SMTL ID : 6vn3.2 (1 other biounit)

USP7 IN COMPLEX WITH LIGAND COMPOUND 23

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.73 Å

Oligo State

monomer

Ligands

1 x R3Y: 1-{[7-(5-chloro-2-{[(3R,4S)-4-fluoropyrrolidin-3-yl]oxy}-3-methylphenyl)thieno[3,2-b]pyridin-2-yl]methyl}-1H-pyrrole-2,5-dione(Non-covalent)

R3Y.1: 15 residues within 4Å: Chain A: Y.19, M.87, H.89, D.90, V.91, Q.92, L.201, M.202, R.203, F.204, H.251, N.255, Y.260, N.307, Y.309 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:Y.19, A:D.90, A:F.204, A:F.204, A:H.251, A:Y.260, A:Y.309, A:Y.309, A:Y.309 Hydrogen bonds: A:D.90, A:D.90, A:V.91, A:Q.92, A:R.203, A:F.204, A:Y.260 pi-Stacking: A:F.204

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Leger, P.R. et al., Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity. J.Med.Chem. (2020)

Release Date

2020-04-29

Peptides

Ubiquitin carboxyl-terminal hydrolase 7: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Ubiquitin carboxyl-terminal hydrolase 7

Related Entries With Identical Sequence